GENDER AND AGE RELATED DIFFERENCES IN IMPLANTABLE DEFIBRILLATOR RECIPIENTS: RESULTS FROM THE PACEMAKER AND IMPLANTABLE DEFIBRILLATOR LEADS SURVIVAL STUDY ("PAIDLESS")

A. Feldman, D. Kersten, J. Chung, W. Asheld, J. Germano, S. Islam, T. Cohen

A. Feldman, D. Kersten, J. Chung, W. Asheld, J. Germano, S. Islam, T. Cohen

Abstract

Introduction: This study investigated the influences of gender and age on defibrillator lead failure and mortality.
Methods: Gender and age were analyzed with respect to lead failure and mortality in a retrospective single center study. Subjects included all Winthrop University Hospital patients that underwent defibrillator lead implantation between 1996 and 2011. Statistical analyses included Fisher’s Exact Test, Kaplan-Meier analysis, and multivariable Cox regression models.
Results: The study included 3802 patients (2812 men/990 women). Leads implanted in women failed more quickly than in men ages 45 to 54 (p=0.0341). Multivariable Cox regression models confirmed male gender as an independent protective factor of lead failures between the ages of 45 and 54 [HR=0.37(0.14, 0.96), p=0.042]. Lead survival time for these women was 13.4(SE=0.6) years versus 14.7(SE=0.3) years in men. No differences in mortality were found.
Conclusions: This study is the first to compare lead failure and mortality in relation to gender and age at a large implanting center. This study emphasizes the complex interplay between gender and age with respect to lead failure and mortality and the need for future research.


Figure 1. Kaplan-Meier lead survival curve by gender for ages 45-54